Q2 2025 Holdings
Filed 2025-08-14 | 15 holdings | $346.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $82.5M | 1,568,841 | 23.8% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $82.2M | 6,746,951 | 23.8% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $61.3M | 5,404,674 | 17.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $40.5M | 733,014 | 11.7% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $33.1M | 4,400,842 | 9.6% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $12.5M | 11,057,009 | 3.6% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $11.4M | 7,857,347 | 3.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $10.2M | 7,098,133 | 2.9% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $4.4M | 1,036,051 | 1.3% |
| Passage BIO Inc | COM | 702712100 | $3.7M | 9,256,953 | 1.1% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $2.4M | 219,247 | 0.7% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $1.2M | 1,538,573 | 0.3% |
| Neuphoria Therapeutics Inc(NEUP) | COM | 64136E102 | $325.2K | 45,806 | 0.1% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $222.3K | 65,954 | 0.1% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $187.8K | 10,366 | 0.1% |